Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

NXTC holding history

NextCure, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NXTC overviewAll 13F holders of NXTCFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of NXTC by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−15,292−100.0%Sold outHolders
Q1 202615,292$160.9K<0.1%+15,292NewHolders
Q3 20250$00.0%−4,904−100.0%Sold outConverted for a 1-for-12 splitHolders
Q2 202558,845$27.1K<0.1%−31,798−35.1%ReducedHolders
Q1 202590,643$43.5K<0.1%+11,965+15.2%AddedHolders
Q4 202478,678$60.7K<0.1%+22,724+40.6%AddedHolders
Q3 202455,954$76.7K<0.1%−233,096−80.6%ReducedHolders
Q2 2024289,050$459.6K<0.1%+43,574+17.8%AddedHolders
Q1 2024245,476$547.4K<0.1%−130,374−34.7%ReducedHolders
Q4 2023375,850$428.5K<0.1%−62,760−14.3%ReducedHolders
Q3 2023438,610$565.8K<0.1%+45,347+11.5%AddedHolders
Q2 2023393,263$707.9K<0.1%−86,584−18.0%ReducedHolders
Q1 2023479,847$710.2K<0.1%−42,317−8.1%ReducedHolders
Q4 2022522,164$736.3K<0.1%+48,067+10.1%AddedHolders
Q3 2022474,097$1.30M<0.1%+80,731+20.5%AddedHolders
Q2 2022393,366$1.85M<0.1%+3,377+0.9%AddedHolders
Q1 2022389,989$1.90M<0.1%−3,647−0.9%ReducedHolders
Q4 2021393,636$2.36M<0.1%−3,079−0.8%ReducedHolders
Q3 2021396,715$2.67M<0.1%−314,909−44.3%ReducedHolders
Q2 2021711,624$5.71M<0.1%−348,794−32.9%ReducedHolders
Q1 20211,060,418$10.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.